73,941 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Acquired by Yousif Capital Management LLC

Yousif Capital Management LLC bought a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 73,941 shares of the company’s stock, valued at approximately $1,788,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Means Investment CO. Inc. lifted its position in shares of Hims & Hers Health by 23.5% during the 4th quarter. Means Investment CO. Inc. now owns 50,040 shares of the company’s stock valued at $1,210,000 after acquiring an additional 9,508 shares during the last quarter. Ausbil Investment Management Ltd purchased a new stake in shares of Hims & Hers Health during the fourth quarter valued at $127,000. Genesee Capital Advisors LLC acquired a new position in shares of Hims & Hers Health in the 4th quarter valued at $889,000. Perigon Wealth Management LLC purchased a new position in Hims & Hers Health in the 4th quarter worth about $337,000. Finally, Pacer Advisors Inc. acquired a new stake in Hims & Hers Health during the 4th quarter worth about $374,000. 63.52% of the stock is currently owned by institutional investors.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, CEO Andrew Dudum sold 33,513 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $33.38, for a total transaction of $1,118,663.94. Following the completion of the transaction, the chief executive officer now owns 33,502 shares of the company’s stock, valued at $1,118,296.76. The trade was a 50.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Soleil Boughton sold 2,343 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $29.90, for a total transaction of $70,055.70. Following the sale, the insider now owns 165,254 shares of the company’s stock, valued at $4,941,094.60. This trade represents a 1.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,043,867 shares of company stock worth $30,839,478. 17.71% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HIMS. Citigroup downgraded shares of Hims & Hers Health from a “neutral” rating to a “sell” rating and lifted their target price for the stock from $24.00 to $25.00 in a research report on Friday, January 10th. Needham & Company LLC boosted their target price on shares of Hims & Hers Health from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, January 6th. Bank of America cut Hims & Hers Health from a “buy” rating to an “underperform” rating and decreased their target price for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upped their price target on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research report on Wednesday, November 6th. Finally, Canaccord Genuity Group raised their price objective on Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Hims & Hers Health presently has a consensus rating of “Hold” and an average price target of $25.13.

Hims & Hers Health Trading Down 2.7 %

Shares of NYSE:HIMS opened at $43.56 on Wednesday. The stock has a market capitalization of $9.52 billion, a PE ratio of 99.01 and a beta of 1.35. Hims & Hers Health, Inc. has a 1 year low of $9.14 and a 1 year high of $46.01. The firm has a fifty day moving average price of $30.73 and a 200 day moving average price of $23.58.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.